Houston Methodist Research Institute
Houston, Texas, United States
Hospital in Houston, Texas
6670 Bertner Ave, Houston, TX 77030
About Houston Methodist Research Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
The Methodist Hospital Research Institute
11
Eli Lilly and Company
6
Abbott Medical Devices
5
United Therapeutics
5
Daiichi Sankyo, Inc.
4
Amgen
3
Baxalta now part of Shire
3
Boston Scientific Corporation
3
C. R. Bard
3
Celgene
3
Reata Pharmaceuticals, Inc.
3
Clinical Trials at Houston Methodist Research Institute
During the past decade, Houston Methodist Research Institute conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 46 clinical trials were completed, i.e. on
average, 59% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 27 clinical trials were completed. i.e. 108%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
2006-08-01
2013-06-01
Completed
3,445
Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)
2005-05-01
2007-08-01
Completed
39
KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures
2006-08-01
2011-07-01
Terminated
404
Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer
2006-12-01
2009-06-01
Completed
55
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancer
2006-05-01
2007-05-01
Completed
27
Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer
2006-12-01
2008-09-01
Terminated
9
A Phase II Study of EC17 (Folate-hapten Conjugate) in Patients With Progressive Metastatic Renal Cell Carcinoma
2007-06-01
2009-03-01
Terminated
12
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Houston Methodist Research Institute" #1 sponsor was "The Methodist Hospital Research Institute" with 11 trials, followed by "Eli Lilly and Company" with 6 trials
sponsored, "Abbott Medical Devices" with 5 trials sponsored, "United Therapeutics" with 5 trials sponsored and "Daiichi Sankyo, Inc."
with 5 trials sponsored. Other sponsors include 94 different institutions and
companies that sponsored additional 84 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Research Institute"
#1 collaborator was "AstraZeneca" with 3 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 3 trials as a collaborator, "The Methodist Hospital Research Institute" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were
collaborators in the rest 43 trials.
Clinical Trials Conditions at Houston Methodist Research Institute
According to Clinical.Site data, the most researched conditions in "Houston Methodist Research Institute" are
"Breast Cancer" (6 trials), "Atrial Fibrillation" (5 trials), "Pulmonary Hypertension" (5 trials), "Paroxysmal Atrial Fibrillation" (4 trials) and "Pulmonary Arterial Hypertension" (4 trials). Many other conditions were trialed in "Houston Methodist Research Institute" in a lesser frequency.
Clinical Trials Intervention Types at Houston Methodist Research Institute
Most popular intervention types in "Houston Methodist Research Institute" are "Drug" (68 trials), "Device" (36 trials), "Other" (14 trials), "Biological" (10 trials) and "Procedure" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "Gemcitabine" (3 trials), "Oral treprostinil" (3 trials), "placebo" (3 trials) and "AG-348" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Houston Methodist Research Institute
The vast majority of trials in "Houston Methodist Research Institute" are
120 trials for "All" genders, 7 trials for "Male" genders and 3 trials for "Female" genders.
Clinical Trials Status at Houston Methodist Research Institute
Currently, there are NaN active trials in "Houston Methodist Research Institute".
undefined are not yet recruiting,
15 are recruiting,
16 are Active, not recruiting,
and 5 are Enrolling by invitation.
In total, there were 65 completed trials in Houston Methodist Research Institute,
1 suspended trials,
and 21 terminated clinical trials to date.
Out of the total trials that were conducted in Houston Methodist Research Institute, 11 "Phase 1"
clinical trials were conducted, 29 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 31 trials that are defined as “Not Applicable".